Long-Term Protection from SARS-CoV-2 Variants in Mice by a Phase II Clinically Evaluated Original mRNA Vaccine Booster

Long-Term Protection from SARS-CoV-2 Variants in Mice by a Phase II Clinically Evaluated Original mRNA Vaccine Booster

The global coronavirus disease 2019 (COVID-19) pandemic was caused by SARS-CoV-2. The authors developed an mRNA vaccine (LVRNA009) that encoded the S protein of the Wuhan-Hu-1 strain and evaluated the long-term protection potential against SARS-CoV-2 variants. Mice were initially vaccinated with 2 d...

Full description

Saved in:
Bibliographic Details
Main Authors: Jun Liu, Jing Sun, Liping Luo, Yanhong Tang, Hu Guo, Yiyun He, Qi Liu, Xuya Yu, Yumei Huang, Siyuan Zhang, Airu Zhu, Jun Dai, Fan Zhang, Tao Huang, Jincun Zhao, Yucai Peng
Format: Article
Language:English
Published: Compuscript Ltd 2024-04-01
Series:Zoonoses
Online Access:https://www.scienceopen.com/hosted-document?doi=10.15212/ZOONOSES-2023-0060
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.scienceopen.com/hosted-document?doi=10.15212/ZOONOSES-2023-0060

Similar Items